Large Molecule Biologics Development

Large Molecule Biologics Development
Product Description

Modalities: monoclonal antibodies, Fab fragments, Fc fusion proteins, recombinant proteins, and ADC intermediates 

Scale: pilot-scale single-use bioreactors from 3 L to 500 L for process development and characterization 

Stage coverage: preclinical and early phase through late-stage and commercial tech transfer readiness 

Sites: process and analytical development at our Toronto facility, drug product testing and stability support at our Cincinnati facility 

Network: entirely within our North American footprint 

Resilience

  • Country/Region:
    United States
  • Founded:
    2020
  • On CPHI since:
    2023
  • Certificates:
    4
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Drug delivery device Supplier/Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Analytical Services
Biopharmaceutical
Contract Manufacturer
Intermediates Manufacturer
Packaging & drug delivery
Pharmaceutical Company (innovator finished products)
Supply Chain
Technology
Specifications
  • Details
    Development and Analytical covers the work that happens before a molecule reaches commercial-scale GMP production: choosing or receiving a cell line, building and characterizing the upstream and downstream process, and developing and validating the analytical methods that will test it at every stage after. 

Resilience

  • Country/Region:
    United States
  • Founded:
    2020
  • On CPHI since:
    2023
  • Certificates:
    4
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Drug delivery device Supplier/Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Analytical Services
Biopharmaceutical
Contract Manufacturer
Intermediates Manufacturer
Packaging & drug delivery
Pharmaceutical Company (innovator finished products)
Supply Chain
Technology

More Products from Resilience (4)

  • Device Assembly, Packaging & Logistics

    Product Device Assembly, Packaging & Logistics

    Device platforms: autoinjector, accessorized prefilled syringe, and cartridge assembly, supporting APFS, Ypsomed, and SHL platforms, plus additional device and proprietary platforms [TK: confirm current platform list] 

    Packaging: labeling, serialization, and aggregation across bulk, multi-u...
  • Drug Substance Manufacturing

    Product Drug Substance Manufacturing

    Modalities: monoclonal antibodies, recombinant proteins (including complex and non-cytotoxic conjugated), fusion proteins, enzymes, bispecifics, and plasma proteins 

    Scale: single-use bioreactors 3L to 500L (development) and 50L to 2,000L (manufacturing) 

    Stage coverage: pre...
  • Parenteral Drug Product Manufacturing

    Product Parenteral Drug Product Manufacturing

    Parenteral Formats: vials, accessorized prefilled syringes, autoinjectors, pen injectors, and cartridges 

    Formulation: parenteral aseptic liquid, including adjuvant, suspension, and other complex presentations 

    Finishing: 100% visual inspection, device assembly, packaging, s...
  • Sterile Fill/Finish

    Product Sterile Fill/Finish

    Formats: vials, pre-filled syringes, and cartridges 

    Fill technology: isolator- and RABS-based automated and semi-automated lines 

    Sites: Toronto and Cincinnati, both commercially licensed 

    Stage coverage: clinical and commercial, GMP and non-GMP 
    ...